NEOSTIGMINE METHYLSULFATE (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the NEOSTIGMINE METHYLSULFATE drug offered from Par Pharmaceutical, Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | NEOSTIGMINE METHYLSULFATE |
| SUBSTANCE NAME: | NEOSTIGMINE METHYLSULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
NEOSTIGMINE METHYLSULFATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | NEOSTIGMINE METHYLSULFATE from Par Pharmaceutical, Inc. |
| LABELER NAME: | Par Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/mL) |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42023-188_9806e051-5d81-42ee-bb60-841d711d544e |
| PRODUCT NDC: | 42023-188 |
| APPLICATION NUMBER: | ANDA208405 |
Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers:
